Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Regulus Therapeutics Inc

CUSIP: 75915K901 | 6 institutional holders

Quarters

Q3 2018 Q4 2017 Q2 2017 Q1 2017 Q4 2016

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile